Nuwellis announces US patent issuance for hemolysis sensor technology supporting pediatric device Vivian

Nuwellis, Inc.

US Patent No. 12,415,021 issued September 16, 2025, for hemolysis sensors with extracorporeal blood filtration systems.
Patent covers detection and localization of red blood cell destruction in ultrafiltration and CRRT circuits.
Intellectual property supports Nuwellis' pediatric device Vivian and future platform innovation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.